Comparison of oral and subcutaneous iron chelation therapies in the prevention of major endocrinopathies in beta-thalassemia major patients. [electronic resource]
Producer: 20060829Description: 257-62 p. digitalISSN:- 0363-0269
- Administration, Oral
- Adolescent
- Adult
- Chelation Therapy -- methods
- Child
- Combined Modality Therapy
- Deferiprone
- Deferoxamine -- administration & dosage
- Diabetes Mellitus -- etiology
- Dwarfism, Pituitary -- etiology
- Endocrine System Diseases -- etiology
- Female
- Human Growth Hormone -- deficiency
- Humans
- Hypogonadism -- etiology
- Infusions, Parenteral
- Iron Chelating Agents -- administration & dosage
- Iron Overload -- drug therapy
- Male
- Patient Compliance
- Puberty, Delayed -- etiology
- Pyridones -- administration & dosage
- Subcutaneous Tissue
- Transfusion Reaction
- beta-Thalassemia -- complications
No physical items for this record
Publication Type: Comparative Study; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.